Cardiovascular Disease in Type 2 DiabetesMellitus: Progress toward personalised management

Cardiovascular Disease in Type 2 Diabetes Mellitus: Progress toward personalised management

Cardiovascular diseases (CVDs) are the main cause of death among patients with type 2 diabetes mellitus (T2DM), particularly in low‑ and middle‑income countries. To effectively prevent the development of CVDs in T2DM, considerable effort has been made to explore novel preventive approaches, individualised glycaemic control and cardiovascular risk management (strict blood pressure and lipid control), together with recently developed glucose‑lowering agents and lipid‑lowering drugs. This is a shortened version of the original review.

Modern Medicine – Issue 3 2023